VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES
Japan
2022-144109
Filed on 2022-09-09
2022-144109
Filed on 2022-09-09
PREFUSION PIV F IMMUNOGENS AND THEIR USE
European Patent
23156040.0
Filed on 2017-10-25
23156040.0
Filed on 2017-10-25
RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS
France
16838103.6
Filed on 2016-12-12
16838103.6
Filed on 2016-12-12
Compositions And Methods For Treating Malaria
Patent Cooperation Treaty
PCT/US2022/013223
Filed on 2022-01-22
PCT/US2022/013223
Filed on 2022-01-22
COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY
Hong Kong
62022057259.3
Filed on 2022-07-25
62022057259.3
Filed on 2022-07-25
RECOMBINANT RESPIRATORY SYNCYTIAL VIRUS (RSV) STRAINS COMPRISING NS1 AND NS2 GENE SHIFTS
Ireland
16838103.6
Filed on 2016-12-12
16838103.6
Filed on 2016-12-12
Self-assembling Nanoparticles Based On Amphiphilic Peptides
Patent Cooperation Treaty
PCT/US2022/016600
Filed on 2022-02-16
PCT/US2022/016600
Filed on 2022-02-16
CD47-targeted Therapies For The Treatment Of Infectious Disease
European Patent
22185801.2
Filed on 2022-07-19
22185801.2
Filed on 2022-07-19
Broadly Neutralizing and Potent Antibodies Against HIV
US Application 17/778,536
Filed on 2022-05-20
Filed on 2022-05-20